Frederick E. Durr

Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones

K. C. Murdock, Ralph G. Child, P. F. FABIO et al. · Journal of Medicinal Chemistry · 1979 · 283 citations

Medicinal Chemistry, Antitumor Agents, Medicine +10

Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics.

Lois M. Hinman, Philip R. Hamann, Ryan M. Wallace et al. · PubMed · 1993 · 238 citations

Rhamnose Residue, Calicheamicin Family, Pharmacotherapy +22

Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice.

Roslyn E. Wallace, K. C. Murdock, Robert B. Angier et al. · PubMed · 1979 · 149 citations

Chemoprevention Strategy, Immunology, Metronomic Chemotherapy +18

Studies on the infectivity and cytopathology of epstein‐barr virus in human lymphoblastoid cells

Frederick E. Durr, James H. Monroe, Rene W. Schmitter et al. · International Journal of Cancer · 1970 · 82 citations

Epstein‐barr Virus, Viral Replication, Human Lymphoblastoid Cells +19

An Anti-MUC1 Antibody−Calicheamicin Conjugate for Treatment of Solid Tumors. Choice of Linker and Overcoming Drug Resistance

Philip R. Hamann, Lois M. Hinman, Carl F. Beyer et al. · Bioconjugate Chemistry · 2005 · 74 citations